Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 11, 2025

GUTHRIE INTRODUCES NEW K9 SECURITY TEAM
Sayre, Pa., April 11, 2025 (GLOBE NEWSWIRE) -- Sayre, Pa. – In another proactive step to promote workplace safety, Guthrie introduced its first-ever K9 Security Team on Friday, April 11. Echo Cardiogram Guthrie -- Echo for short -- and his handler, K9 …

Inaugural international seed funding initiative successfully advances global research collaborations
Toronto, April 11, 2025 (GLOBE NEWSWIRE) -- TORONTO, April 11, 2025 - The inaugural funding call of the Global Research Excellence (GRE) Fund has concluded with York providing over $225,000 to support international research collaboration. Launched in the …

Ultra runner Wataru Iino has completed his running journey across the continents of North and South America.
The runner was delighted to have covered a total of 25,000 km in his quest to cross the five continents. USHUAIA, ARGENTINA, April 11, 2025 /EINPresswire.com/ -- Japanese ultra-runner Wataru Iino, who is sponsored by Lucent Corporation (Headquarters: …

Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
HENDERSON, Nev., April 11, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) published a report on the therapeutic effect and potential economic impact of ITV-1. The document contains the company’s findings on the effects of the drug on …

Joule Health & Wellbeing Launches Same-Day Stress Support Services
Spokane, WA, April 11, 2025 (GLOBE NEWSWIRE) -- As part of National Stress Awareness Month, Joule Health …

New Mexico Donor Services Honors Donor Heroes, Families During Donate Life Month
ALBUQUERQUE, N.M., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, New Mexico Donor Services and Donate Life New Mexico celebrate Donate Life Month, paying tribute to everyone who said “yes” to giving the gift of life through organ, eye and …

Tennessee Donor Services Honors Donor Heroes, Families During Donate Life Month
NASHVILLE, Tenn., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, Tennessee Donor Services and Donate Life Tennessee celebrate Donate Life Month, paying tribute to everyone who said “yes” to giving the gift of life through organ, eye and …

Sierra Donor Services Honors Donor Heroes, Families During Donate Life Month
SACRAMENTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, Sierra Donor Services and Donate Life California celebrate Donate Life Month, paying tribute to everyone who has said “yes” to giving the gift of life through organ, eye and …

Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, …

Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it …

BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction and Elevated Markers of Cardiac Stress Dr. Arshed Quyyumi, Professor of Medicine, Division of Cardiology, …

Scilex Holding Company Announces 1-for-35 Reverse Stock Split
PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …

Preliminary Results for the Year Ended 31 December 2024
April 11, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical …

US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6% CAGR | MarketsandMarkets™.
Delray Beach, FL, April 11, 2025 (GLOBE NEWSWIRE) -- The US Radiotherapy Market is projected to reach US$2.49 billion by 2030 from US$3.25 billion in 2024, at a CAGR of 4.6%. The US radiotherapy market is growing due to ongoing technological innovations …

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …

Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 386, …

ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
- Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC - - Additional podium presentation to provide updates from long-term evaluation of Padeliporfin VTP in intermediate-risk prostate cancer - TEL AVIV, Israel, April 11, …

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on April 2, 2025 to 18 new …

Palvella Therapeutics Announces QTORIN™ Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermatology at Northwestern University’s Feinberg School of …
Presentation highlighted the recent expansion of the Phase 3 SELVA trial to include children 3 to 5 years old Presentation reviewed clinically and statistically significant Phase 2 results and the design of the ongoing Phase 3 SELVA trial Top-line results …

Optima Health to acquire Cognate Health Limited
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) …